full report - UCT - Research Report 2011

Uys, P., Marais, B.J., Johnstone-Robertson, S., Hargrove,
J. and Wood, R. 2011. Transmission Elasticity in
Communities Hyperendemic for Tuberculosis. Clinical
Infectious Diseases, 52(12): 1399-1404.
Valesky, W., Silverberg, M., Gillet, B., Roblin, P., Adelaine, J.,
Wallis, L.A., Smith, W.P. and Arquilla, B. 2011. Assessment
of Hospital DisasterPreparedness for the 2010 FIFA World
CupUsing an Internet-based, Long-distanceTabletop Drill.
Prehospital and Disaster Medicine, 26(3): 192-195.
Valley-Omar, Z., Meyers, A.E., Shephard, E.G., Williamson,
A.-.L. and Rybicki, E.P. 2011. Abrogation of contaminating
RNA activity in HIV-1 Gag VLPs. Virology Journal, 8(2011):
E462(12). www.virologyj.com/content/8/1/462.
van Der Plas, H. and Mendelson, M. 2011. High prevalence
of comorbidity and need for up-referral among inpatients
at a district-level hospital with specialist tuberculosis
services in South Africa - the need for specialitst support.
SAMJ South African Medical Journal, 101(8): 529-532.
Van Der Ventel, M., Nieuwenhuizen, N., Kirstein, F., Hikuam,
C., Jeebhay, M.F., Swoboda, I., Brombacher, F. and Lopata,
A.L. 2011. Differential responses to natural and recombinant
allergens in a murine model of fish allergy. Molecular
Immunology, 48: 637-646.
van der Watt, P., harrison, T.B., Benatar, M. and Heckmann,
J.M. 2011. Polyneuropathy,anti-tuberculosis treatment and
the role of pyridoxine in the HIV/AIDS ERA:a systematic
review. International Journal of Tuberculosis and Lung
Disease, 15(6): 722-728.
Van Ingen, J., Donald, P.R. and Dawson, R. 2011. Why do
we use 600 mg of rifampicin in tuberculosis treatment?
Clinical Infectious Diseases, 52(May): e194-e199.
van Zyl, G.U., van Mens, T.E., McIlleron, H., Zeier, M.,
Nachega, J.B., Decloedt, E.H., Malavazzi, M., Smith, P.J.,
Huang, Y., van der Merwe, L., Gandhi, M. and Maartens, G.
2011. Low Lopinavir Plasma or Hair Concentration Explain
Second-Line Protease Inhibitor Failures in a Resource-
Limited Setting. Jaids-Journal of Acquired Immune
Deficiency Syndromes, 56(4): 333-339.
Van Zyl-Smit, R., Binder, A.B., Meldau, R., Mishra, H., Semple,
P.L., Theron, G., Peter, J., Whitelaw, A.C., Sharma, S.K., Warren,
R.M., Bateman, E.D. and Dheda, K. 2011. Comparison of
quantitative techniques including Xpert MTB/RIF to evaluate
mycobacterial burden. PLoS One, 6(12): e28815. (10pp)
Visser, M.M.E., Grewal, H.M.S., Swart, E.C., Dhansay, M.,
Walzl, G., Swanevelder, S., Lombard, C. and Maartens,
G. 2011. The effect of vitamin A and zinc supplementation
on treatment outcomes in pulmonary tuberculosis:
a randomized controlled trial(1-3). American Journal of
Clinical Nutrition, 93: 93-100.
FACULTY OF heALTh sCienCes
Visser-Kift, E., Kredo, T. and Barnes, K.I. 2011. Parenteral
artesunate access programme aims at reducing malaria
fatality rates in South Africa. SAMJ S South African Medical
Journal, 101(4): 240-241.
Walensky, R.P., Wood, R., Fofana, M.O., Martinson, N.,
Losina, E., April, M.D., Bassett, I.V., Morris, B.L., Freedberg,
K.A. and Paltiel, A.D. 2011. The Clinical Impact and
Cost-Effectiveness of Routine, Voluntary HIV Screening in
South Africa. Jaids-Journal of Acquired Immune Deficiency
Syndromes, 56(1): 26-35.
Wang, B., Losina, E., Stark, R., Munro, A., Walensky, R.P.,
Wilke, M., Martin, D.J., Lu, Z., Freedberg, K.A. and Wood,
R. 2011. Loss to follow-up in a community clinic in South
Africa - roles of gender, pregnancy and CD4 count. SAMJ
South African Medical Journal, 101(4): 253-257.
Watkins, D.A., Omokhodion, S.I. and Mayosi, B.M. 2011.
The history of the Pan-African Society of Cardiology
(PASCAR): the first 30 years, 1981-2011. Cardiovascular
Journal of Africa, 22(3): 122-123.
Weinreich, C., Ross, I.L., Kotze, T., Levitt, N. and Steyn,
R.E. 2011. Carcinoid heart disease: Two clinical cases
and a review. Journal of Endocrinology, Metabolism and
diabetes of South Africa (JEMDSA), 16(1): 58-63.
Wen, L., Geduld, H., Nagurney, J. and Wallis, L.A. 2011.
Africas First Emergency Medicine Training Program at the
University of CapeTown Stellenbosch University: History,
Progress, and Lessons Learned. Academic Emergency
Medicine, 18(8): 868-871.
Whitelaw, A.C., Peter, J., Sohn, H., Viljoen, D., Theron,
G., Badri, M., Davids, V., Pai, M. and Dheda, K. 2011.
Comparative cost and perfomance of light-emitting diode
microscopy in HIV-tuberculosis-co-infected patience.
European Respiratory Journal, 38: 1393-1397.
Wiesner, J., Govender, K., Meredith, S.A., Norman, J.J.
and Smith, P.J. 2011. A liquid-liquid LC/MS/MS assay for
the determination of artemether and DHA in malaria patient
samples. Journal of Pharmaceutical and Biomedical
Analysis, 55: 373-378.
Wijewardana, I., Jarvis, J.N., Meintjes, G., Harrison, T.
and Bicanic, T. 2011. Large volume lumbar punctures in
cryptococcal meningitis clear cryptococcal antigen as
well as lowering pressure. Letter to the editor. Journal of
Infection, 63: 484-486.
Wilkins, J., Langdon, G., McIlleron, H., Pillai, G., Smith,
P.J. and Simonsson, U. 2011. Variability in the population
pharmacokinetics of isoniazid in South African tuberculosis
patients. British Journal of Clinical Pharmacology, 72(1): 51-62.
Wilson, D., Badri, M. and Maartens, G. 2011. Performance
335